血浆ADA2活性与ADA2变异的诊断意义及相关性
基于200例DADA2国际队列,血浆ADA2活性区分基因确诊DADA2与对照的敏感性99.0%、特异性99.7%,与携带者区分敏感性96.0%、特异性98.8%。9%的DADA2患者可检测到残余ADA2活性,与血管炎/炎症表型相关但与疾病严重程度无关。体外研究显示错义ADA2变异通过Cys408二硫键形成蛋白聚集体产生显性负效应。
要点
- 血浆ADA2活性诊断DADA2敏感性99.0%、特异性99.7%,与携带者区分敏感性96.0%、特异性98.8%。
- 9%的DADA2患者可检测到残余ADA2活性,部分达携带者水平,与血管炎/炎症表型相关。
- 18例残余活性中14例携带至少一个低效错义变异,293T细胞过表达时残余功能>20%。
核心结论
- 血浆ADA2活性可作为DADA2诊断检测,DADA2炎症表型可出现在有残余ADA2活性的病例中。
- 体外结果显示ADA2变异可通过Cys408二硫键形成蛋白聚集体产生可变显性负效应,协同破坏蛋白功能。
研究设计与样本
- 研究纳入2018至2025年接受ADA2检测的个体,利用200例DADA2病例的国际队列。
- 血浆ADA2活性采用已建立的分光光度法测定;ADA2变异在转染细胞中通过酶活性和western blotting分析。
主要发现
- 血浆ADA2活性区分基因确诊DADA2与对照的敏感性99.0%、特异性99.7%,区分DADA2与携带者的敏感性96.0%、特异性98.8%。
- 18例DADA2患者(9%)具有可检测的ADA2活性,包括若干例水平与携带者所见相同。
- 残余ADA2活性与血管炎/炎症表型相关,但与疾病严重程度无关。
- 18例残余血浆活性病例中14例携带至少一个低效错义变异,在293T细胞过表达时残余ADA2功能大于20%,常与一个更有害的变异反式出现。
- 体外分析显示错义ADA2变异通过Cys408半胱氨酸残基形成二硫键产生大分子细胞内蛋白聚集体,发挥可变显性负效应。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Deficiency of adenosine deaminase 2 (DADA2) is a monogenic autoinflammatory disease manifested as polyarteritis nodosa, stroke, and bone marrow failure. Leveraging an international cohort of 200 DADA2 cases, we aimed to characterize the diagnostic utility of a plasma ADA2 enzyme activity assay and understand the implications of residual ADA2 activity. METHODS: Data were collected from individuals who underwent ADA2 testing from 2018 to 2025. Plasma ADA2 activity was determined using an established spectrophotometric assay. ADA2 variants were analyzed in transfected cells by enzyme assay and western blotting. RESULTS: We determined that plasma ADA2 activity is 99.0% and 96.0% sensitive and 99.7% and 98.8% specific in distinguishing genetically confirmed DADA2 cases from controls and carriers, respectively. Eighteen individuals with DADA2 (9%) possessed detectable ADA2 activity, including several cases with levels seen in carriers. Residual ADA2 activity was associated with the vasculitis/inflammatory phenotype but not with disease severity. Genotype analysis revealed that 14 of 18 cases with residual plasma activity possessed at least one hypomorphic missense variant with greater than 20% residual ADA2 function when overexpressed in 293T cells, often occurring in trans with a more deleterious variant. In vitro analysis revealed that missense ADA2 variants exert variable dominant-negative effects by forming large intracellular protein aggregates via disulfide bond formation at a cysteine residue (Cys408). CONCLUSION: We confirmed the utility of plasma ADA2 activity as a diagnostic assay and showed that the inflammatory phenotype of DADA2 occurred in cases with residual activity. In vitro findings illustrate potential interactions of ADA2 variants to synergistically disrupt protein function.
引用
- Yue J, LeSon CE, Rimland CA, et al. Diagnostic Implications and Correlates of Plasma Adenosine Deaminase 2 Activity and ADA2 Variants. Arthritis Rheumatol. 2025. PMID: 41147740. doi:10.1002/art.43412
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。